✦ LIBER ✦

A phase I trial of vandetanib combined with capecitabine, oxaliplatin and bevacizumab for the first-line treatment of metastatic colorectal cancer

✍ Scribed by Elwyn C. Cabebe, George A. Fisher, Branimir I. Sikic

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

667 PUBLICATION Capecitabine and oxalipl

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Bevacizumab with FOLFOXIRI (irinotecan,

✍ Gianluca Masi; Fotios Loupakis; Lisa Salvatore; Lorenzo Fornaro; Chiara Cremolin 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 269 KB

Bevacizumab in combination with biweekly

✍ García-Alfonso, P; Muñoz-Martin, A J; Alvarez-Suarez, S; Jerez-Gilarranz, Y; Rie 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 243 KB

Phase I/II trial of capecitabine and oxa

✍ Hoehler, T; von Wichert, G; Schimanski, C; Kanzler, S; Moehler, M H; Hinke, A; S 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 202 KB

133 A phase II study of oxaliplatin, cap

✍ N. Fernando; M. Morse; G. Blobe; L. Sutton; L. Odogwu; W. Honeycutt; M. Bauer; M 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 144 KB

6110 POSTER Combination Chemotherapy Wit

✍ Bazarbashi, S.; Aljubran, A.; Soudy, H.; Alzahrani, A.; Darwish, A.; Eltaigani, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB